Inventage Lab

Inventage Lab Enterprise Value

The Enterprise Value (EV) of Inventage Lab (389470.KQ) as of Oct 21, 2026 is 1.12 T KRW. In the previous year, Enterprise Value (EV) was 1.13 T KRW — a change of -1.23% (lower).

Enterprise Value

1.12 TKRW

YoY

-1.23%

Last updated:

Enterprise Value (EV) of Inventage Lab is 2025 1.12 T KRW. Enterprise Value (EV) of Inventage Lab was 2024 1.13 T KRW. It decreases by -1.23% lower compared to the previous year.

The Inventage Lab Enterprise Value history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Enterprise Value
Date
Enterprise Value
Jan 1, 2019
1.11 T KRW
Jan 1, 2020
1.11 T KRW
Jan 1, 2021
1.10 T KRW
Jan 1, 2022
1.12 T KRW
Jan 1, 2023
1.12 T KRW
Jan 1, 2024
1.13 T KRW
Jan 1, 2025
1.12 T KRW
The Inventage Lab Enterprise Value history
YEAREnterprise ValueYoY
1.12 TKRW-1.23%
1.13 TKRW+0.50%
1.12 TKRW+0.71%
1.12 TKRW+1.65%
1.10 TKRW-0.74%
1.11 TKRW-0.64%
1.11 TKRW—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Inventage Lab Stock analysis

What does Inventage Lab do? Inventage Lab, Inc. generates revenue through the research, manufacture, and sale of human medicines targeting male pattern baldness, dementia, and prostate cancer, as well as veterinary medicines including combination drugs and chemical castration agents. The company leverages its proprietary platforms for long-acting injections and genetic material drug delivery to develop and scale production of these products. Its human medicine segment focuses on therapeutic areas with significant market demand, while veterinary medicines serve agricultural and companion animal markets. The firm's business model centers on proprietary technology platforms applied to both human and veterinary pharmaceutical development. These platforms enable the company to create and mass-produce innovative drug delivery systems, which are critical for the efficacy of their medicine portfolios. Revenue streams are derived from direct sales of these medicines to healthcare providers and veterinary institutions within their target markets. Inventage Lab, Inc. operates with a dual focus on human and veterinary pharmaceuticals, utilizing its specialized platforms to address unmet medical needs in both sectors. The company's product range includes treatments for specific conditions like male pattern baldness and prostate cancer, alongside veterinary applications such as chemical castration agents, which are sold to relevant industry stakeholders in their respective markets. Inventage Lab is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Inventage Lab stock

Enterprise Value (EV) of Inventage Lab is 1.12 T KRW in 2025.

Enterprise Value (EV) of Inventage Lab changed from 1.13 T KRW to 1.12 T KRW, representing a -1.23% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Enterprise Value (EV) Inventage Lab since 2006 – with annual values, charts, and detailed analysis.

Enterprise Value represents the total value of a company, including both equity and debt, minus cash. It provides a more comprehensive picture than market capitalization alone.

EV = Market Capitalization + Total Debt - Cash & Equivalents

To evaluate Enterprise Value (EV)'s KRW, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Enterprise Value (EV).

A 'good' KRW varies by industry and company stage. On Eulerpool, you can compare Enterprise Value (EV)'s Inventage Lab with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Valuation — Inventage Lab

All Key Metrics — Inventage Lab